Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage company specializing in “off-the-shelf” allogeneic cell therapy products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback